Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Gabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, Katharina Blatt, Gregor Eisenwort, Wolfgang R. Sperr, Gregor Hoermann, Karin Lind, Alexander W. Hauswirth, Peter Bettelheim, Heinz Sill, Junia V. Melo, Ulrich Jäger, Peter Valent
Published Jun 28, 2017 · Vol. 8, No. 40 · pp. 67709-67722
Sonja Helbig, Leesa Wockner, Annick Bouendeu, Ursula Hille-Betz, Karen McCue, Juliet D. French, Stacey L. Edwards, Hilda A. Pickett, Roger R. Reddel, Georgia Chenevix-Trench, Thilo Dörk, Jonathan Beesley
Published May 26, 2017 · Vol. 8, No. 40 · pp. 67203-67217
Laura Gragnani, Elisa Fognani, Valli De Re, Massimo Libra, Adriana Garozzo, Patrizio Caini, Guia Cerretelli, Andrea Giovannelli, Serena Lorini, Monica Monti, Silvia Bagnoli, Irene Piaceri, Anna Linda Zignego
Published May 6, 2017 · Vol. 8, No. 42 · pp. 71528-71535